TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common malignancy of the liver. Genomic analysis is conducted to identify genetic alterations in driver genes which are all druggable targets for cancer therapy. In the present study, we performed an exome sequencing of 45 driver genes in 100 paired samples...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncol Rep
Main Authors: Ye, Song, Zhao, Xin-Yi, Hu, Xiao-Ge, Li, Tang, Xu, Qiu-Ran, Yang, Huan-Ming, Huang, Dong-Sheng, Yang, Liu
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2017
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5367355/
https://ncbi.nlm.nih.gov/pubmed/28350084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5494
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker